Find a Clinical Trial
Is a clinical trial right for you? Search our database to find studies for which you may be eligible.
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Alpelisib BYL719 in Combination with Nab-Paclitaxel in Patients with Advanced Triple Negative Breast Cancer with Either Phosphoinositide-3-Kinase Catalytic Subunit Alpha PIK3CA Mutation or Phosphatase and Tensin Homolog Protein PTEN Loss Without PIK3CA Mutation
Randomized Open-Label Trial of Dose Dense, Fixed Dose Capecitabine Compared to Standard Dose Capecitabine in Metastatic Breast Cancer and Advanced/Metastatic GI Cancers
Pilot Study of Effects of Duavee� on Imaging and Blood Biomarkers In Women with Menopausal Symptoms at Increased Risk for Breast Cancer
Study Type: Prevention
Phase: Feasibility/Pilot
NCTID: NCT04379024
Principal Investigator:
Carol Fabian
A Randomized Phase III Double Blinded Placebo Controlled Trial of Aspirin as Adjuvant Therapy for HER2 Negative Breast Cancer: The ABC Trial
Neoadjuvant TIL- and Response-Adapted Chemoimmunotherapy for TNBC NeoTRACT
Elacestrant Monotherapy for the Treatment of Postmenopausal Women with ER+/HER2- Advanced Breast Cancer Following Cdk4/6 Inhibitor Therapy: A Phase III Randomized, Open-Label, Multicenter Trial EMERALD
Study Type: Treatment
Phase: III
NCTID: NCT03778931
Principal Investigator:
Prospective evaluation of GErmline mutations, Cancer outcome and Tissue biomarkers P.R.O.G.E.C.T.: A registry for patients with triple negative breast cancer and germline mutations
Randomized Phase III Trial Evaluating the Role of Weight Loss in Adjuvant Treatment of Overweight and Obese Women with Early Breast Cancer
Study Type: Treatment
Phase: III
NCTID: NCT02750826
Principal Investigator:
Jennifer Klemp